Kaiser Permanente, the nation’s largest nonprofit, integrated health system, announced that it is joining with nonprofit Civica Rx in its mission of assuring that health providers nationally have access to stable and affordable supplies of essential generic medications throughout the COVID-19 pandemic and beyond.
| OAKLAND, Calif., June 18, 2020 /PRNewswire/ -- Kaiser Permanente, the nation’s largest nonprofit, integrated health system, announced that it is joining with nonprofit Civica Rx in its mission of assuring that health providers nationally have access to stable and affordable supplies of essential generic medications throughout the COVID-19 pandemic and beyond.
Kaiser Permanente joins Civica as a governing member with a seat on the board of directors and as an integrated health system with 12.4 million members will provide an important voice in designing Civica’s future strategy. The addition of Kaiser Permanente comes at a time when Civica is already delivering 20 essential generic medications, 10 of which are currently being used to treat COVID-19 patients. Civica is also working to significantly boost generic drug production within the United States. “At Kaiser Permanente, we know that our members and all Americans need access to affordable medications for emergency care and to support recovery from illness and management of chronic conditions,” said Kaiser Permanente Chairman and CEO Greg Adams. “The COVID-19 pandemic has put a spotlight on the critical need for ensuring consistent supplies of affordable, generic medications for patients and we are proud to join with Civica Rx to help lead these efforts.” Civica Rx was founded in 2018 by leading U.S. health systems concerned with shortages of essential generic drugs and philanthropic organizations passionate about improving health care. Today, more than 50 health systems are Civica members, representing more than 1,200 hospitals and over 30% of all licensed U.S. hospital beds. “Kaiser Permanente is one of the country’s most respected health organizations and we are honored they are joining Civica at a moment when the U.S. and the world are grappling with this public health emergency and uncertainty about a second wave for COVID-19,” said Martin VanTrieste, Civica’s CEO. “We will greatly value their expertise and input on the board during this urgent time of need.” Kaiser Permanente has a deep commitment to lowering prescription drug prices and reducing barriers to generic and biosimilar drug adoption. Kaiser Permanente dispenses 90 million prescriptions and administers 54 million inpatient and clinic doses annually. About Civica Rx About Kaiser Permanente For more information, contact:
SOURCE Kaiser Permanente |
View original content to download multimedia:
